BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
BioHarvest Sciences (NASDAQ: BHST), a pioneer in Botanical Synthesis technology, has scheduled its Q2 2025 earnings conference call for August 11, 2025, at 8:00 a.m. Eastern Time. The company will release its financial results for the quarter ended June 30, 2025, before the market opens.
The conference call will include a corporate update and a Q&A session. Participants can join via U.S./Canada dial-in (1-877-300-8521) or International dial-in (1-412-317-6026) using Conference ID 0083058. A replay will be available through August 25, 2025, and can be accessed via webcast or telephone playback.
BioHarvest Sciences (NASDAQ: BHST), pioniere nella tecnologia di Sintesi Botanica, ha programmato la sua conference call per i risultati del secondo trimestre 2025 l'11 agosto 2025 alle 8:00 ora Eastern. L'azienda pubblicherà i risultati finanziari per il trimestre terminato il 30 giugno 2025 prima dell'apertura dei mercati.
La conference call includerà un aggiornamento aziendale e una sessione di domande e risposte. I partecipanti potranno collegarsi tramite chiamata dagli Stati Uniti/Canada (1-877-300-8521) o internazionale (1-412-317-6026) utilizzando il codice di conferenza 0083058. Una registrazione sarà disponibile fino al 25 agosto 2025 e potrà essere ascoltata via webcast o tramite riproduzione telefonica.
BioHarvest Sciences (NASDAQ: BHST), pionera en tecnología de Síntesis Botánica, ha programado su conferencia telefónica de resultados del segundo trimestre de 2025 para el 11 de agosto de 2025 a las 8:00 a.m. hora del Este. La compañía publicará sus resultados financieros para el trimestre finalizado el 30 de junio de 2025 antes de la apertura del mercado.
La conferencia incluirá una actualización corporativa y una sesión de preguntas y respuestas. Los participantes pueden unirse mediante llamada desde EE.UU./Canadá (1-877-300-8521) o llamada internacional (1-412-317-6026) usando el ID de conferencia 0083058. Una repetición estará disponible hasta el 25 de agosto de 2025 y podrá accederse vía webcast o reproducción telefónica.
BioHarvest Sciences (NASDAQ: BHST)는 식물 합성 기술의 선구자로서, 2025년 8월 11일 오전 8시(동부 표준시)에 2025년 2분기 실적 컨퍼런스 콜을 예정하고 있습니다. 회사는 2025년 6월 30일 마감된 분기의 재무 결과를 시장 개장 전에 발표할 예정입니다.
컨퍼런스 콜에는 기업 업데이트와 질의응답 세션이 포함됩니다. 참가자는 미국/캐나다 내 전화(1-877-300-8521) 또는 국제 전화(1-412-317-6026)를 통해 컨퍼런스 ID 0083058을 사용하여 참여할 수 있습니다. 재청취는 2025년 8월 25일까지 가능하며 웹캐스트 또는 전화 재생을 통해 접속할 수 있습니다.
BioHarvest Sciences (NASDAQ : BHST), pionnier de la technologie de synthèse botanique, a programmé sa conférence téléphonique sur les résultats du deuxième trimestre 2025 le 11 août 2025 à 8h00, heure de l'Est. La société publiera ses résultats financiers pour le trimestre clos le 30 juin 2025 avant l'ouverture des marchés.
La conférence comprendra une mise à jour de l'entreprise et une session de questions-réponses. Les participants peuvent se joindre via un appel depuis les États-Unis/Canada (1-877-300-8521) ou un appel international (1-412-317-6026) en utilisant l'ID de conférence 0083058. Un replay sera disponible jusqu'au 25 août 2025 et accessible via webcast ou lecture téléphonique.
BioHarvest Sciences (NASDAQ: BHST), ein Pionier der Botanischen Synthesetechnologie, hat seine Telefonkonferenz für die Quartalsergebnisse Q2 2025 am 11. August 2025 um 8:00 Uhr Eastern Time angesetzt. Das Unternehmen wird die Finanzergebnisse für das am 30. Juni 2025 endende Quartal vor Markteröffnung veröffentlichen.
Die Telefonkonferenz umfasst ein Unternehmensupdate und eine Fragerunde. Teilnehmer können über eine US-/Kanada-Einwahlnummer (1-877-300-8521) oder eine internationale Einwahlnummer (1-412-317-6026) mit der Konferenz-ID 0083058 teilnehmen. Eine Aufzeichnung ist bis zum 25. August 2025 verfügbar und kann per Webcast oder Telefonwiedergabe abgerufen werden.
- None.
- None.
Rehovot, Israel--(Newsfile Corp. - August 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the second quarter ended June 30, 2025 before market open on Monday, August 11, 2025.
Management will host an investor conference call and webcast at 8:00 a.m. Eastern time on Monday, August 11, 2025 to discuss the Company's second quarter 2025 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:
Second Quarter 2025 Results Conference Call
Date: Monday, August 11, 2025
Time: 8:00 a.m. Eastern time
U.S./Canada Dial-in: 1-877-300-8521
International Dial-in: 1-412-317-6026
Conference ID: 0083058
Webcast: BHST Q2 2025 Earnings Conference Call
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A telephone playback of the call will be available through Monday, August 25, 2025. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 10199237. A webcast replay will also be available at the webcast link above.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHST@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261128
FAQ
When is BioHarvest Sciences (BHST) Q2 2025 earnings call?
How can investors access BioHarvest Sciences' Q2 2025 earnings call?
When will BioHarvest Sciences release its Q2 2025 financial results?
How long will the BHST Q2 2025 earnings call replay be available?
